Cadista has temporarily discontinued losartan tablets due to issues with obtaining active ingredient
The last Recall Enforcement Report for Losartan Potassium 25 Mg with NDC 64380-933 was initiated on 06-26-2023 as a Class II recall due to presence of foreign substance: presence of a small piece of blue plastic embedded in the tablet
S
Product labels associated with the lots being recalled will be posted to the FDA website under Recalls and Alerts
Besides hypertension, it is also used in diabetic kidney disease, heart failure, and left ventricular enlargement
With the exception of neonatal weight gain (which was affected at doses as low as 10 mg/kg/day), doses associated with these effects exceeded 25 mg Losartan Potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and ">" on the other side
Doctors regularly prescribed antihypertensive drugs like Losartan, Valsartan, and Irbesartan to millions of patients in the United States and worldwide
The dosage can be increased to a maximum dose of 100 mg once daily as needed to control blood pressure [see Clinical Studies (14
NDC Finished Product Strength and Package Count Batch Number Expiration Date; 13668-113-90: Losartan Potassium Tablets, USP 25mg, 90 count: 4DU1E005: 1/31/2021 Uses
Quantity: 3288/30 count bottles; 23,904/90 count bottles; 3364/1000 count bottles = 5,614,000 tablets: Recall Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits: Drug Classification: Class II: Drug Code Info:
Losartan is used alone or together with other medicines to treat high blood pressure (hypertension)
Mendenhall, Memphis, TN 38141